BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8245630)

  • 21. [Hemostatic tests for the diagnosis of thrombosis. Activated coagulation and fibrinolytic factors. Detection of the protease/inhibitor complex].
    Iijima K
    Rinsho Byori; 1988 Jun; 36(6):623-6. PubMed ID: 2974894
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of haemostatic molecular markers for diagnosis of disseminated intravascular coagulation in patients with infections.
    Asakura H; Wada H; Okamoto K; Iba T; Uchiyama T; Eguchi Y; Kawasugi K; Koga S; Mayumi T; Koike K; Gando S
    Thromb Haemost; 2006 Feb; 95(2):282-7. PubMed ID: 16493490
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Use of chromogenic substrates for the diagnosis of blood coagulation and fibrinolytic disorders].
    Bokarev IN; Butorov VN; Loginov LE
    Ter Arkh; 1981; 53(2):118-24. PubMed ID: 6452714
    [No Abstract]   [Full Text] [Related]  

  • 24. [Molecular markers of hemostatic mechanisms--thrombin-antithrombin III complex].
    Fukutake K
    Rinsho Byori; 1989 Mar; 37(3):261-5. PubMed ID: 2664281
    [No Abstract]   [Full Text] [Related]  

  • 25. [Analysis of the fibrinolytic response on disseminated intravascular coagulation].
    García Frade LJ; García Avello A
    Sangre (Barc); 1993 Jun; 38(3):221-4. PubMed ID: 7692611
    [No Abstract]   [Full Text] [Related]  

  • 26. Preeclampsia as chronic disseminated intravascular coagulation. Study of two parameters: thrombin-antithrombin III complex and D-dimers.
    Kobayashi T; Terao T
    Gynecol Obstet Invest; 1987; 24(3):170-8. PubMed ID: 3319818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High plasma fibrinogen level is associated with poor clinical outcome in DIC patients.
    Wada H; Mori Y; Okabayashi K; Gabazza EC; Kushiya F; Watanabe M; Nishikawa M; Shiku H; Nobori T
    Am J Hematol; 2003 Jan; 72(1):1-7. PubMed ID: 12508260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Problems of diagnosis of disseminated intravascular coagulation (DIC).
    Bowie EJ; Owen CA
    Southeast Asian J Trop Med Public Health; 1979 Sep; 10(3):325-7. PubMed ID: 515796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Antithrombin III in the acute promyelocytic leukemias].
    Roncalés FJ; Juncá J; Tuset E
    Sangre (Barc); 1994 Apr; 39(2):148-9. PubMed ID: 8059294
    [No Abstract]   [Full Text] [Related]  

  • 30. [Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
    Chuecas F; Loredo E; Muñoz B; Alfaro J; Grebe G; Lira P
    Rev Med Chil; 1991 Sep; 119(9):984-9. PubMed ID: 1845106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Thrombin-antithrombin III complex (TAT): a marker for activation of intravascular coagulation].
    Seitz R; Egbring R; Wagner C; Dati F
    Internist (Berl); 1990 Jan; 31(1):69-74. PubMed ID: 2407683
    [No Abstract]   [Full Text] [Related]  

  • 32. Diagnosis of disseminated intravascular coagulation by hemostatic molecular markers.
    Wada H; Gabazza E; Nakasaki T; Shimura M; Hiyoyama K; Deguchi K; Nishikawa M; Sakuragawa N; Shiku H
    Semin Thromb Hemost; 2000; 26(1):17-21. PubMed ID: 10805276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The importance of the enzyme preparation ancistron-N in the diagnosis of disseminated intravascular coagulation].
    Neĭko EM; Serediuk NN; Fabrika AV
    Vrach Delo; 1990 Apr; (4):57-60. PubMed ID: 2275170
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunochemical determination of thrombin-antithrombin III and plasmin-antiplasmin complexes in human plasma.
    Collen D
    Verh K Acad Geneeskd Belg; 1979; 41(2):81-166. PubMed ID: 160714
    [No Abstract]   [Full Text] [Related]  

  • 35. [Changes in coagulation parameters during the clinical courses of recipients of living-related partial liver transplantation].
    Okumura N; Matsuzawa A; Terasawa F; Sasaki Y; Nakagoshi R; Ishikawa S; Hashikura Y; Matsunami H; Kawasaki S; Makuuchi M
    Rinsho Byori; 1995 Aug; 43(8):829-35. PubMed ID: 7474443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].
    Koga S
    Rinsho Byori; 2004 Apr; 52(4):355-61. PubMed ID: 15164605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cross-linked fibrin polymer and degradation products by plasmin (XDP)].
    Kawai Y
    Nihon Rinsho; 2004 Dec; 62 Suppl 12():618-22. PubMed ID: 15658405
    [No Abstract]   [Full Text] [Related]  

  • 38. Advanced neuroblastoma and disseminated intravascular coagulation: report of six cases.
    Hatae Y; Takeda T; Hattori T; Nakadate H; Nishi M
    Jpn J Clin Oncol; 1985 Sep; 15(3):483-8. PubMed ID: 4057631
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anti-heparin/PF4 complexes by ELISA in patients with disseminated intravascular coagulation.
    Matsuo T; Matsuo M; Sugimoto T; Wanaka K
    Pathophysiol Haemost Thromb; 2007; 36(6):305-10. PubMed ID: 20224256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Measurement of thrombin-antithrombin III complex in plasma].
    Kuroso K; Koike K; Ikematsu S; Fujimaki M
    Rinsho Byori; 1988 Dec; 36(12):1421-5. PubMed ID: 3074186
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.